The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan - Zage, P E; Graham, T C; Zeng, L (Cancer, 2011)
et al.